Form 4: Corvus Pharmaceuticals Executive Acquires Stock Options

William Benton Jones, SVP of Pharmaceutical Development at Corvus Pharmaceuticals, acquired stock options for 300,000 shares on December 20, 2024.

Summary

• William Benton Jones, SVP of Pharmaceutical Development at Corvus Pharmaceuticals, filed a Form 4.
• The filing reports a transaction on December 20, 2024, where Jones acquired stock options for 300,000 shares of Corvus Pharmaceuticals common stock.
• The exercise price of the options is $4.99 per share.
• The options vest in equal monthly installments over three years, starting December 20, 2024, contingent upon continued service with the company.
• The options expire on December 20, 2034.

Sentiment

Score: 6

Explanation: The document itself is neutral, reporting a standard executive compensation event. The sentiment is slightly positive as it indicates executive alignment with company goals.

Positives

• The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule suggests a long-term commitment from the executive to the company.

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded pharmaceutical companies.
• The vesting schedule of 3 years is typical for such grants, aligning executive incentives with long-term company performance.
• The specific number of options granted and the exercise price would need to be compared to similar companies of comparable size and stage of development to assess whether the grant is above or below industry averages.

Stakeholder Impact

• The stock option grant aligns the executive's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.

Key Dates